Recent studies have begun to investigate the role of HIF-2α in RA, with initial results demonstrating a potential role as a catabolic factor (Huber et al., 2006; Ryu et al., 2014; Huh et al., 2015). Here, EPAS1 is linked to rheumatoid arthritis.